- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06518772
The Effect of Hot Perfoming on the Soles of the Feet in the First Stage of Labor on Labor
July 19, 2024 updated by: HATİCE YEŞİLKAYA, Cumhuriyet University
This research was conducted to determine the effect of applying heat to the soles of the feet during the active phase (5-10 cm dilation) of the first stage of labor.
It is a randomized controlled experimental study.
In the intervention group, hot gel packs with a temperature of 40-42°C were applied to the soles of the feet for 20 minutes when the cervical dilation was 5 cm.
These applications were repeated in the same manner at one-hour intervals until the cervical dilation reached 10 cm.
The procedure was terminated when the cervical dilation reached 10 cm.
Routine services were applied to the control group.
Data were collected using a personal information form, Partograph form, APGAR score, Visual Analog Scale (VAS), and Birth Satisfaction Scale Short Form (BSS-SF)
Study Overview
Detailed Description
This research was conducted to determine the effect of applying heat to the soles of the feet during the active and transition phase (4-10 cm dilation) of the first stage of labor.
The research is a randomized controlled experimental study and is conducted in Sivas Cumhuriyet University Practice and Research Hospital Maternity Unit.
When the sample size was taken as α = 0.05 and β = 0.10 and 1-β = 0.90 to represent the population in the research, there were 30 individuals in each group and the power of the test was found to be P = 0.90640.
The application procedure started with the application of hot gel packets at a temperature of 40-42°C to the soles of the feet of the women in the intervention group for 20 minutes when cervical dilation reaches 5 cm.
The first Visual Analog Scale (VAS) evaluation was conducted after the application.
Conduction is followed by more evaluations at the 25th (5 minutes after the application), 35th (15 minutes after the application), and 50th minute (30 minutes after the application).
These applications were repeated every hour until cervical dilation reached 10 cm.
The applicatilon procedure has been stopped after cervical dilation reached 10 cm.
The control group received routine service and VAS at the same times.
Data were collected with personal information form, Partograph form, APGAR score, Visual Analog Scale (VAS) and Birth Satisfaction Scale Short Form (BSS-R) Wilcoxon test, Mann Whitney U test, Chi-square test, Exact test, Friedman test, t test were used to evaluate the data.
The data error level was accepted as 0.05.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sivas, Turkey, 58000
- Sivas Cumhuriyet University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 1. The pregnant woman must be 19 years or older 2. 38-42. being in the gestational age, 3. Having a singleton pregnancy, 4. The fetus is in a vertex position, 5. Cervical dilatation is 5 cm. to be, 6. Not having a diagnosed chronic physical disease, 7. Not having a diagnosed psychiatric disease, 8. Absence of risky pregnancy and birth, 9. There is no abnormality in the fetus, 10. Being able to speak Turkish and be literate 11. Having a primigravida
Exclusion Criteria:
- Not meeting inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
The application procedure started with the application of hot gel packets at a temperature of 40-42°C to the soles of the feet of the women in the intervention group for 20 minutes when cervical dilation reaches 5 cm.The first Visual Analog Scale (VAS) evaluation was conducted after the application.
Conduction is followed by more evaluations at the 25th (5 minutes after the application), 35th (15 minutes after the application), and 50th minute (30 minutes after the application).
These applications were repeated every hour until cervical dilation reached 10 cm.
The applicatilon procedure has been stopped after cervical dilation reached 10 cm.
|
The application procedure started with the application of hot gel packets at a temperature of 40-42°C to the soles of the feet of the women in the intervention group for 20 minutes when cervical dilation reaches 5 cm.
|
|
No Intervention: Control
The control group received routine service and VAS at the same times.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: Before application
|
VAS provides rapid measurement of pain intensity in clinical and laboratory conditions.
In VAS, the patient is asked to make a mark on a 10 cm horizontal line showing the current situation.
In this study, for pain; Markings are made on a 10 cm horizontal line, one end of which indicates the patient's pain is very good (0 = no pain) and the other end is very bad (10 = most severe).
|
Before application
|
|
Visual Analog Scale
Time Frame: 25 minutes after initial pain assessment
|
VAS provides rapid measurement of pain intensity in clinical and laboratory conditions.
In VAS, the patient is asked to make a mark on a 10 cm horizontal line showing the current situation.
In this study, for pain; Markings are made on a 10 cm horizontal line, one end of which indicates the patient's pain is very good (0 = no pain) and the other end is very bad (10 = most severe).
|
25 minutes after initial pain assessment
|
|
Visual Analog Scale
Time Frame: 35 minutes after initial pain assessment
|
VAS provides rapid measurement of pain intensity in clinical and laboratory conditions.
In VAS, the patient is asked to make a mark on a 10 cm horizontal line showing the current situation.
In this study, for pain; Markings are made on a 10 cm horizontal line, one end of which indicates the patient's pain is very good (0 = no pain) and the other end is very bad (10 = most severe).
|
35 minutes after initial pain assessment
|
|
Visual Analog Scale
Time Frame: 50 minutes after initial pain assessment
|
VAS provides rapid measurement of pain intensity in clinical and laboratory conditions.
In VAS, the patient is asked to make a mark on a 10 cm horizontal line showing the current situation.
In this study, for pain; Markings are made on a 10 cm horizontal line, one end of which indicates the patient's pain is very good (0 = no pain) and the other end is very bad (10 = most severe).
|
50 minutes after initial pain assessment
|
|
Birth Satisfaction Scale Short Form
Time Frame: Application of the birth satisfaction scale 2-4 hours after birth
|
The scale consists of 10 items and is a Likert type scale.
It is scored as "I strongly agree (4 points)", "I agree (3 points)", "I am undecided (2 points)", "I disagree (1 point)", "I strongly disagree (0 points)".
2, 4, 7 of the scale.
Items , and 8 are calculated in reverse and the lowest score from the scale is "0" and the highest score is "40".
As the score increases, the level of birth satisfaction increases.
Scale cut-off scores <13 are low satisfaction, 14-27 are medium satisfaction, >28 are high.
The scale has three sub-dimensions: quality of care (3,5,6,10), personal characteristics (8.4) and stress experience (1,2,7,9).
The total score that can be obtained from the quality of care sub-dimension is 16.
The total score that can be obtained from the personal characteristics sub-dimension is 8 and the total score that can be obtained from the stress experience sub-dimension is 16.
|
Application of the birth satisfaction scale 2-4 hours after birth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Durations of birth stages with partograph form
Time Frame: during labor
|
The partograph form is based on recording the developments observed during labor by specifying the time, and recording begins when the woman enters the active phase (cervical dilatation of 5-6 cm).
This form not only shows the progress of the action, but also determines the deviation of the process from normal.
In the partograph; There are three parameters that show the progress of birth, the health status of the baby and the health status of the mother.
To determine the progress of labor; Cervical dilation, level of the baby's head, frequency and duration of uterine contractions in 10 minutes are monitored and recorded.
To evaluate the baby's health status; The fetal heart rate (every 30 minutes), the presence of the amniotic membrane at each vaginal examination, the color of the fluid and the descent of the fetal head are evaluated and recorded.
|
during labor
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Handan Guler, Assoc. Prof., Cumhuriyet University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Actual)
December 15, 2023
Study Completion (Actual)
December 15, 2023
Study Registration Dates
First Submitted
July 19, 2024
First Submitted That Met QC Criteria
July 19, 2024
First Posted (Actual)
July 24, 2024
Study Record Updates
Last Update Posted (Actual)
July 24, 2024
Last Update Submitted That Met QC Criteria
July 19, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- cumhuriyetuniv
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.